Name |
Default Value |
Used for Staging |
NAACCR Item |
Required By |
Grade Clinical |
9 |
true |
#3843 |
COC_REQUIRED
NPCR_REQUIRED
CCCR_REQUIRED
SEER_REQUIRED |
Grade Pathological |
9 |
true |
#3844 |
COC_REQUIRED
NPCR_REQUIRED
CCCR_REQUIRED
SEER_REQUIRED |
Grade Post Therapy Clin (yc) |
null |
true |
#1068 |
NPCR_REQUIRED
COC_REQUIRED
SEER_REQUIRED |
Grade Post Therapy Path (yp) |
null |
true |
#3845 |
COC_REQUIRED
NPCR_REQUIRED
CCCR_REQUIRED
SEER_REQUIRED |
Lymph Nodes Positive Axillary Level I-II |
X8 |
true |
#3882 |
COC_REQUIRED
SEER_REQUIRED |
ER Summary |
9 |
true |
#3827 |
COC_REQUIRED
NPCR_REQUIRED
CCCR_REQUIRED
SEER_REQUIRED |
ER Percent Positive |
XX8 |
false |
#3826 |
COC_REQUIRED
SEER_REQUIRED_WHEN_COC_ANALYTIC |
ER Allred Score |
X8 |
false |
#3828 |
COC_REQUIRED
SEER_REQUIRED_WHEN_COC_ANALYTIC |
PR Summary |
9 |
true |
#3915 |
COC_REQUIRED
NPCR_REQUIRED
CCCR_REQUIRED
SEER_REQUIRED |
PR Percent Positive |
XX8 |
false |
#3914 |
COC_REQUIRED
SEER_REQUIRED_WHEN_COC_ANALYTIC |
PR Allred Score |
X8 |
false |
#3916 |
COC_REQUIRED
SEER_REQUIRED_WHEN_COC_ANALYTIC |
HER2 Overall Summary |
9 |
true |
#3855 |
COC_REQUIRED
NPCR_REQUIRED
CCCR_REQUIRED
SEER_REQUIRED |
HER2 IHC Summary |
8 |
false |
#3850 |
COC_REQUIRED
CCCR_REQUIRED
SEER_REQUIRED_WHEN_COC_ANALYTIC |
HER2 ISH Summary |
8 |
false |
#3854 |
COC_REQUIRED
CCCR_REQUIRED
SEER_REQUIRED_WHEN_COC_ANALYTIC |
HER2 ISH DP Ratio |
XX.8 |
false |
#3852 |
COC_REQUIRED
SEER_REQUIRED_WHEN_COC_ANALYTIC |
HER2 ISH DP Copy No |
XX.8 |
false |
#3851 |
COC_REQUIRED
SEER_REQUIRED_WHEN_COC_ANALYTIC |
HER2 ISH SP Copy No |
XX.8 |
false |
#3853 |
COC_REQUIRED
SEER_REQUIRED_WHEN_COC_ANALYTIC |
Ki-67 (MIB-1) |
XXX.8 |
false |
#3863 |
COC_REQUIRED
SEER_REQUIRED_WHEN_COC_ANALYTIC |
Oncotype DX Recur Score - Invasive |
XX9 |
true |
#3904 |
COC_REQUIRED
CCCR_REQUIRED
SEER_REQUIRED |
Oncotype Dx Risk Level - Invasive |
8 |
false |
#3906 |
COC_REQUIRED
SEER_REQUIRED_WHEN_COC_ANALYTIC |
Oncotype DX Recur Score - DCIS |
XX8 |
false |
#3903 |
COC_REQUIRED
SEER_REQUIRED_WHEN_COC_ANALYTIC |
Oncotype Dx Risk Level - DCIS |
8 |
false |
#3905 |
COC_REQUIRED
SEER_REQUIRED_WHEN_COC_ANALYTIC |
Multigene Signature Method |
8 |
false |
#3894 |
COC_REQUIRED
SEER_REQUIRED |
Multigene Signature Result |
X8 |
false |
#3895 |
COC_REQUIRED
SEER_REQUIRED |
Response Neoadjuv Therapy |
8 |
false |
#3922 |
COC_REQUIRED
SEER_REQUIRED_WHEN_COC_ANALYTIC |